北大医药(000788.SZ)：提请股东大会授权以公司生产制造中心为基础组建生产制造子公司

Core Viewpoint - The company, Peking University Pharmaceutical (000788.SZ), is planning a strategic adjustment to its existing manufacturing system to enhance operational efficiency and core competitiveness in response to new trends in the pharmaceutical industry [1] Group 1 - The company aims to optimize resource allocation and promote high-quality development of its main business [1] - A proposal has been made by major shareholders to establish a manufacturing subsidiary based on the company's production center located in the Chongqing Beibei District [1] - The company will seek authorization from the shareholders' meeting for this strategic initiative [1]